Your browser doesn't support javascript.
loading
MRPL13 is a metastatic and prognostic marker of breast cancer: A silico analysis accompanied with experimental validation.
Dai, Pei; Chen, Yan'an; Zhang, Xiao; Liu, Long; Cheng, Zhenbo.
Afiliação
  • Dai P; Department of Medical Laboratory, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Hunan Normal University, 410005 Changsha, Hunan Province, China. Electronic address: daipei930115@163.com.
  • Chen Y; Department of Laboratory Medicine, Hunan Normal University, School of Medicine, 410081 Changsha, Hunan Province, China. Electronic address: 407573555@qq.com.
  • Zhang X; Department of Medical Laboratory, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Hunan Normal University, 410005 Changsha, Hunan Province, China.
  • Liu L; Department of Medical Laboratory, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Hunan Normal University, 410005 Changsha, Hunan Province, China.
  • Cheng Z; Department of Medical Laboratory, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Hunan Normal University, 410005 Changsha, Hunan Province, China. Electronic address: zbcheng88hn@163.com.
Gene ; 932: 148908, 2025 Jan 10.
Article em En | MEDLINE | ID: mdl-39218414
ABSTRACT

BACKGROUND:

Although progress has been made in accurate diagnosis and targeted treatments, breast cancer (BC) patients with metastasis still present a grim prognosis. With the continuous emergence and development of new personalized and precision medicine targeting specific tumor biomarkers, there is an urgent need to find new metastatic and prognostic biomarkers for BC patients.

METHODS:

We were dedicated to identifying genes linked to metastasis and prognosis in breast cancer through a combination of in silico analysis and experimental validation.

RESULTS:

A total of 25 overlap differentially expressed genes were identified. Ten hub genes (namely MRPL13, CTR9, TCEB1, RPLP0, TIMM8B, METTL1, GOLT1B, PLK2, PARL and MANBA) were identified and confirmed. MRPL13, TCEB1 and GOLT1B were shown to be associated with the worse overall survival (OS) and were optionally chosen for further verification by western blot. Only MRPL13 was found associated with cell invasion, and the expression of MRPL13 in metastatic BC was significantly higher than in primary BC.

CONCLUSION:

We proposed MRPL13 could be a potential novel biomarker for the metastasis and prognosis of breast cancer.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simulação por Computador / Neoplasias da Mama / Biomarcadores Tumorais Limite: Female / Humans / Middle aged Idioma: En Revista: Gene Ano de publicação: 2025 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simulação por Computador / Neoplasias da Mama / Biomarcadores Tumorais Limite: Female / Humans / Middle aged Idioma: En Revista: Gene Ano de publicação: 2025 Tipo de documento: Article País de publicação: Holanda